Cte Group Spolka Akcyjna Logo

Cte Group Spolka Akcyjna

LPS | WAR

Overview

Corporate Details

ISIN(s):
PLLRPSP00015 (+4 more)
LEI:
259400L72C5LYIFMI528
Country:
Poland
Address:
CHORZÓW 75 PUŁKU PIECHOTY 1, 41-500 CHORZÓW
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Cte Group S.A., formerly Lauren Peso Polska S.A., is a diversified company operating across three distinct business segments. The first division offers comprehensive B2B services, including business training, HR consulting, and coaching, focusing on customized solutions derived from detailed client needs analysis. The second segment specializes in organizing corporate integration and teambuilding events. The third area of activity involves the research, development, and production of advanced composite materials. Leveraging its scientific personnel and patented technologies, the company works on the commercial application of innovative material solutions for various industries.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Cte Group Spolka Akcyjna. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2023-05-29 06:39
Quarterly Report
Śródroczne skrócone skonsolidowane sprawozdanie finansowe za 1 kw. 2023
Polish 8.3 MB
2023-04-28 18:06
Management Discussion and Analysis
Oświadczenie Zarządu
Polish 10.5 KB
2023-04-28 18:06
Annual Report
Oświadczenie Zarządu
Polish 276.4 KB
2023-04-28 18:06
Annual / Quarterly Financial Statement
Opinia biegłego rewidenta do SSF 2022
Polish 5.5 KB
2023-04-28 18:06
Audit Report / Information
Opinia biegłego rewidenta do SSF 2022
Polish 3.5 MB
2023-04-28 18:06
Management Discussion and Analysis
Sprawozdanie Zarzadu z działalności 2022
Polish 10.5 KB
2023-04-28 18:06
Annual Report
Sprawozdanie Zarządu z działalności 2022
Polish 17.4 MB
2023-04-28 18:06
Annual Report
SSF 2022
Polish 21.2 KB
2023-04-28 18:06
Annual Report (ESEF)
SSF 2022
Polish 7.9 MB
2023-04-28 18:06
Pre-Annual General Meeting Information
List do Akcjonariuszy
Polish 10.5 KB
2023-04-28 18:06
Management Discussion and Analysis
List do Akcjonariuszy
Polish 97.6 KB
2023-04-28 18:02
Management Discussion and Analysis
Oświadczenie Zarządu
Polish 10.5 KB
2023-04-28 18:02
Management Discussion and Analysis
Oświadczenie Zarządu
Polish 271.3 KB
2023-04-28 18:02
Pre-Annual General Meeting Information
List do Akcjonariuszy
Polish 10.5 KB
2023-04-28 18:02
Annual Report
List do Akcjonariuszy
Polish 97.6 KB

Automate Your Workflow. Get a real-time feed of all Cte Group Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Cte Group Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN